These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 7107601)

  • 21. Modulation of the epidermal growth factor receptor by platelet-derived growth factor and choleragen: effects on mitogenesis.
    Wharton W; Leof E; Pledger WJ; O'Keefe EJ
    Proc Natl Acad Sci U S A; 1982 Sep; 79(18):5567-71. PubMed ID: 6291052
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Method for selective labeling of cholera toxin binding region.
    Battistini A; Gallina A; Tomasi M
    Ann Ist Super Sanita; 1983; 19(2-3):379-83. PubMed ID: 6598297
    [No Abstract]   [Full Text] [Related]  

  • 23. Studies on the fate of receptor-bound 125I-interleukin 1 beta in porcine synovial fibroblasts.
    Bird TA; Saklatvala J
    J Immunol; 1987 Jul; 139(1):92-7. PubMed ID: 2953819
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chemical and immunochemical studies on the receptor binding domain of cholera toxin B subunit.
    Ludwig DS; Holmes RK; Schoolnik GK
    J Biol Chem; 1985 Oct; 260(23):12528-34. PubMed ID: 2413025
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Insulin binding, internalization, and receptor regulation in cultured human fibroblasts.
    Baldwin D; Prince M; Tsai P; Johnson C; Lotan R; Rubenstein AH; Olefsky JM
    Am J Physiol; 1981 Sep; 241(3):E251-60. PubMed ID: 7025657
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunocytochemical study on cholera toxin binding sites by monoclonal anti-cholera toxin antibody in neuronal tissue culture.
    Okada E; Maeda T; Watanabe T
    Brain Res; 1982 Jun; 242(2):233-41. PubMed ID: 6811100
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Insulin-cholera toxin binding unit conjugate: a hybrid molecule with insulin biological activity and cholera toxin binding specificity.
    Roth RA; Maddux B
    J Cell Physiol; 1983 May; 115(2):151-8. PubMed ID: 6132923
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The sequence 130-137 of human interferon-alpha 2 is involved in the competition of interferon, prothymosin alpha and cholera toxin B subunit for common receptors on human fibroblasts.
    Zav'Yalov VP; Navolotskaya EV; Vasilenko RN; Abramov VM; Volodina EY; Roslovtseva OA; Prusakov AN; Kaurov OA
    Mol Immunol; 1995 Apr; 32(6):425-31. PubMed ID: 7753051
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Binding of choleragen and anti-ganglioside antibodies to gangliosides incorporated into preformed liposomes.
    Richards RL; Fishman PH; Moss J; Alving CR
    Biochim Biophys Acta; 1983 Sep; 733(2):249-55. PubMed ID: 6882761
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The use of cholera toxin as a probe to study the organisation of ganglioside GM1 in membranes.
    Critchley DR; Kellie S; Streuli CH; Patel B; Ansell S; Pierce E
    Prog Clin Biol Res; 1982; 102 pt A():397-407. PubMed ID: 7167449
    [No Abstract]   [Full Text] [Related]  

  • 31. Inhibition by lactoferrin and kappa-casein glycomacropeptide of binding of Cholera toxin to its receptor.
    Kawasaki Y; Isoda H; Tanimoto M; Dosako S; Idota T; Ahiko K
    Biosci Biotechnol Biochem; 1992 Feb; 56(2):195-8. PubMed ID: 1368296
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Low or undetectable levels of surface high affinity cholera toxin receptors on normal hemopoietic growth factor-dependent cells.
    Lanotte M; Lacaze N
    EMBO J; 1985 Dec; 4(12):3099-104. PubMed ID: 3912166
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The binding potential between the cholera toxin B-oligomer and its receptor.
    Cai XE; Yang J
    Biochemistry; 2003 Apr; 42(14):4028-34. PubMed ID: 12680755
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of cholera toxin activation of the adenylate cyclase system in intact HeLa cells.
    Lin MC; Taniuchi M
    J Cyclic Nucleotide Res; 1980; 6(5):359-67. PubMed ID: 7217459
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Human platelets are defective in processing of cholera toxin.
    Hughes RJ; Insel PA
    Biochem J; 1983 Jun; 212(3):669-78. PubMed ID: 6309151
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Detergent extraction of cholera toxin and gangliosides from cultured cells and isolated membranes.
    Hagmann J; Fishman PH
    Biochim Biophys Acta; 1982 Apr; 720(2):181-7. PubMed ID: 7082684
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Selective expression of cholera toxin-receptor in rat medullary thymocytes.
    Bouchon B; Iwamori M; Masago H; Nagai Y
    Cell Struct Funct; 1987 Aug; 12(4):339-44. PubMed ID: 3304670
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differential binding kinetics of cholera toxin to intestinal microvillus membrane during development.
    Lencer WI; Chu SH; Walker WA
    Infect Immun; 1987 Dec; 55(12):3126-30. PubMed ID: 3679546
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization of the binding of cholera toxin to ganglioside GM1 immobilized onto microtitre plates.
    Dawson RM
    J Appl Toxicol; 2005; 25(1):30-8. PubMed ID: 15669043
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Structure, stability, and receptor interaction of cholera toxin as studied by Fourier-transform infrared spectroscopy.
    Surewicz WK; Leddy JJ; Mantsch HH
    Biochemistry; 1990 Sep; 29(35):8106-11. PubMed ID: 2261465
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.